TY - JOUR
T1 - Muscarinic acetylcholine receptor compounds alter net Ca2+ flux and contractility in an invertebrate smooth muscle
AU - Devlin, C. Leah
AU - Arnole, William
AU - Anderson, Shawn
AU - Shea, Kyle
N1 - Funding Information:
Acknowledgements This work was supported by a Penn State University Abington College FDGrant. Thanks are extended to Dr. Peter Smith, Kasia Hammar, and Jane McLaughlin of the NIH’s Biocurrents Research Center at the Marine Biological Laboratory, Woods Hole, for their expertise on the self-referencing electrodes and support of this work.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2003/11
Y1 - 2003/11
N2 - Responses of a holothurian smooth muscle to a range of muscarinic (M 1 to M5) acetylcholine receptor (mAChR) agonists and antagonists were surveyed using calcium (Ca2+)-selective electrodes and a mechanical recording technique. Most of the mAChR agonists and antagonists tested increased both contractility and net Ca2+ efflux, with M1-specific agents like oxotremorine M being the most potent in their action. To investigate the possible sources of Ca2+ used during mAChR activation, agents that disrupt intracellular Ca2+ ion sequestration [cyclopiazonic acid (CPA), caffeine, ryanodine], the phosphoinositide signaling pathway [lithium chloride (LiCl)], and L-type Ca 2+ channels (diltiazem and verapamil) were used to challenge contractions induced by oxotremorine M. These contractions were blocked by treatment with CPA, caffeine, LiCl, and by channel blockers, diltiazem and verapamil, but were unaltered by ryanodine. Our data suggest that this smooth muscle had an M1,3,5-like receptor that was associated with the phosphoinositide signaling pathway that relied on intracellular Ca2+ stores, but secondarily used extracellular Ca2+ via the opening of L-type channels.
AB - Responses of a holothurian smooth muscle to a range of muscarinic (M 1 to M5) acetylcholine receptor (mAChR) agonists and antagonists were surveyed using calcium (Ca2+)-selective electrodes and a mechanical recording technique. Most of the mAChR agonists and antagonists tested increased both contractility and net Ca2+ efflux, with M1-specific agents like oxotremorine M being the most potent in their action. To investigate the possible sources of Ca2+ used during mAChR activation, agents that disrupt intracellular Ca2+ ion sequestration [cyclopiazonic acid (CPA), caffeine, ryanodine], the phosphoinositide signaling pathway [lithium chloride (LiCl)], and L-type Ca 2+ channels (diltiazem and verapamil) were used to challenge contractions induced by oxotremorine M. These contractions were blocked by treatment with CPA, caffeine, LiCl, and by channel blockers, diltiazem and verapamil, but were unaltered by ryanodine. Our data suggest that this smooth muscle had an M1,3,5-like receptor that was associated with the phosphoinositide signaling pathway that relied on intracellular Ca2+ stores, but secondarily used extracellular Ca2+ via the opening of L-type channels.
UR - http://www.scopus.com/inward/record.url?scp=0347629031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347629031&partnerID=8YFLogxK
U2 - 10.1007/s10158-003-0023-3
DO - 10.1007/s10158-003-0023-3
M3 - Article
C2 - 12687408
AN - SCOPUS:0347629031
SN - 1354-2516
VL - 5
SP - 9
EP - 17
JO - Invertebrate Neuroscience
JF - Invertebrate Neuroscience
IS - 1
ER -